Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Radiotherapy: definitive, integrated and palliative therapy.

The Urologic Clinics of North America

|February 1, 1976

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Heart and kidney transplantation using total lymphoid irradiation and donor bone marrow in mongrel dogs.

The Journal of thoracic and cardiovascular surgery·1980

Same author

The management of testicular seminomas, 1979.

Cancer·1980

Same author

Palliative radiotherapy in the patient with metastatic and advanced incurable cancer.

Wisconsin medical journal·1980

Same author

Evaluation of the Perth experience in treating with ionizing radiations and VHF (434 megahertz) radiations.

International journal of radiation oncology, biology, physics·1979

Same author

Preoperative irradiation of patients with T3 carcinoma in bilharzial bladder.

International journal of radiation oncology, biology, physics·1979

Same author

Clinical instrumentation requirements with a review of the Perth hyperthermia experience.

Cancer research·1979

Same journal

An Unprecedented Era of Innovation in Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026

Same journal

Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome?

The Urologic clinics of North America·2026

Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026

Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026

Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026

Same journal

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026

See all related articles

Muscle-invasive bladder cancer poses significant treatment challenges. Delayed aggressive therapy due to conservative approaches can lead to disease progression, making patients ineligible for curative treatments.

Area of Science:

Oncology
Urology

Background:

Muscle-invasive bladder cancer (MIBC) is a severe oncological condition.
Standard treatment often involves radical cystectomy or chemoradiation.
Conservative management is sometimes employed but frequently leads to disease progression.

Purpose of the Study:

To highlight the challenges in treating muscle-invasive bladder cancer.
To emphasize the risks associated with delayed aggressive therapy.

Main Methods:

This study is a review of clinical outcomes for muscle-invasive bladder cancer patients.
Analysis of treatment pathways and progression rates.

Main Results:

Conservative therapy for MIBC often results in disease progression.

Related Experiment Videos

Delayed initiation of aggressive treatment can render patients unsuitable for curative options.

Conclusions:

Early and definitive treatment is crucial for muscle-invasive bladder cancer.
Procrastination in aggressive therapy for MIBC can have detrimental effects on patient outcomes.